clorazepate dipotassium has been researched along with Pregnancy in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (90.91) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (9.09) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Catala, L; Giniès, JL; Harry, P; Leboucher, B; Malgorn, G; Turcant, A | 1 |
Patel, AR; Patel, DA | 1 |
Corwin, H; DeMyer, W | 1 |
DeMyer, W; Hingtgen, J; Pascuzzi Jackson, V | 1 |
Kanto, JH | 1 |
Olive, G; Rey, E | 1 |
Dvorchik, BH | 1 |
Olive, G; Rey, E; Turquais, JM | 1 |
Challier, JC; d'Athis, P; Guerre-Millo, M; Olive, G; Rey, E; Turquais, JM | 1 |
Chavinie, J; d'Athis, P; Giraux, P; Olive, G; Rey, E; Turquais, JM | 1 |
Chavinie, J; d'Athis, P; de Lauture, D; Giraux, P; Olive, G; Rey, E; Turquais, JM | 1 |
2 review(s) available for clorazepate dipotassium and Pregnancy
Article | Year |
---|---|
Use of benzodiazepines during pregnancy, labour and lactation, with particular reference to pharmacokinetic considerations.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Female; Flunitrazepam; Humans; Infant, Newborn; Labor, Obstetric; Lactation; Lorazepam; Maternal-Fetal Exchange; Nitrazepam; Oxazepam; Pregnancy | 1982 |
[Benzodiazepines and pregnancy. Transplacental passage, labor and lactation].
Topics: Anti-Anxiety Agents; Biotransformation; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Female; Flunitrazepam; Humans; Kinetics; Lorazepam; Maternal-Fetal Exchange; Milk, Human; Nitrazepam; Oxazepam; Postpartum Period; Pregnancy | 1983 |
9 other study(ies) available for clorazepate dipotassium and Pregnancy
Article | Year |
---|---|
[Benzodiazepine poisoning in a neonate: clinical and toxicokinetic evaluation following enterodialysis with activated charcoal].
Topics: Adult; Anti-Anxiety Agents; Charcoal; Clorazepate Dipotassium; Dialysis; Drug Overdose; Female; Half-Life; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Respiration, Artificial; Treatment Outcome | 2004 |
Clorazepate and congenital malformations.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adolescent; Anti-Anxiety Agents; Clorazepate Dipotassium; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy | 1980 |
Failure of clorazepate to cause malformations or fetal wastage in the rat.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Anxiety Agents; Clorazepate Dipotassium; Female; Fetal Death; Fetus; Pregnancy; Rats | 1980 |
Delayed maze-learning in rats after prenatal exposure to clorazepate.
Topics: Animals; Anti-Anxiety Agents; Body Weight; Brain Diseases; Clorazepate Dipotassium; Discrimination Learning; Female; Maternal-Fetal Exchange; Pregnancy; Rats; Reflex | 1980 |
Drug disposition during pregnancy.
Topics: Anti-Bacterial Agents; Clorazepate Dipotassium; Diazepam; Digoxin; Female; Furosemide; Humans; Kidney; Kinetics; Lithium; Liver; Meperidine; Pharmaceutical Preparations; Phenytoin; Pregnancy | 1982 |
[Determination of dipotassium clorazepate in the plasma by gas chromatography (author's transl)].
Topics: Anti-Anxiety Agents; Chromatography, Gas; Clorazepate Dipotassium; Electrons; Female; Humans; Nordazepam; Pregnancy | 1978 |
Transfer in vitro of three benzodiazepines across the human placenta.
Topics: Anti-Anxiety Agents; Clorazepate Dipotassium; Diazepam; Female; Fetus; Humans; Maternal-Fetal Exchange; Perfusion; Placenta; Pregnancy | 1979 |
Pharmacokinetics of the placental transfer and distribution of clorazepate and its metabolite nordiazepam in the feto-placental unit and in the neonate.
Topics: Adult; Amniotic Fluid; Anti-Anxiety Agents; Biotransformation; Clorazepate Dipotassium; Diazepam; Female; Fetus; Humans; Infant, Newborn; Kinetics; Maternal-Fetal Exchange; Placenta; Pregnancy; Time Factors | 1979 |
Pharmacokinetics of clorazepate in pregnant and non-pregnant women.
Topics: Adult; Anti-Anxiety Agents; Biotransformation; Body Fluids; Clorazepate Dipotassium; Female; Half-Life; Humans; Kinetics; Pregnancy | 1979 |